Welcome!
Healthcare
Broker's Calls

Singapore's well-insured ageing population makes this healthcare specialist a choice 'buy' pick
SINGAPORE (July 11): UOB Kay Hian is starting Asian Healthcare Specialists (AHS) at “buy” with a target price of 33 cents as it views the stock as a proxy to increased medical spending from Singapore’s ageing population and rising participation in s
July 11, 2018
IPO

Clearbridge BioMedics receives $6.6 mil in pre-IPO funding ahead of targeted 4Q launch
SINGAPORE (June 28): Clearbridge BioMedics has announced $6.6 million in pre-initial public offering (IPO) funding from oncology medical professionals, as well as investors focused in healthcare & biotechnology.
June 28, 2018

Clearbridge partners Australia's Genome.One for personal health genomics programme
SINGAPORE (June 26): Clearbridge Health (CBH) is partnering Australia-based health information company Genome.One, a wholly-owned subsidiary of Garvan Institute of Medical Research, to offer its patients genomic testing and analysis with the latter’s Ge
June 26, 2018
M&A

Boustead acquires Asia-focused healthcare business for $19 mil
SINGAPORE (May 24): Boustead Singapore announced that it is acquiring 100% of the shareholding of WhiteRock Incorporation (WRI), which comprises a group of 16 healthcare corporations operating in Singapore, China, Hong Kong, Malaysia and Thailand for $19
May 24, 2018
IPO

Hyphens Pharma's public offering 152 times subscribed
SINGAPORE (May 17): Hyphens Pharma International says its public offering of 3 million shares at 26 cents per share in conjunction with its Catalist listing was about 152 times subscribed.
May 17, 2018
Tech

Cordlife launches newborn metabolic screening service in Hong Kong
SINGAPORE (May 2): HealthBaby Biotech (Hong Kong), a wholly-owned subsidiary of Cordlife Group, has launched a newborn metabolic screening service in Hong Kong.
May 02, 2018
Broker's Calls

Is it too early to go into Raffles Medical?
SINGAPORE (May 2): RHB is downgrading its call on Raffles Medical Group (RMG) to “sell” from “neutral” with an unchanged $1.02 target price.
May 02, 2018
IPO

Hyphens Pharma lodges preliminary offer document for Catalist listing
SINGAPORE (Apr 26): Hyphens Pharma International, the specialty pharmaceutical and consumer healthcare group which also owns the Ocean Health brand of supplements, has lodged a preliminary offer document with Singapore Exchange (SGX) to list on its Catali
April 26, 2018
Watch the Cartier Awards Ceremony 'live' from Singapore here
SINGAPORE (Apr 26): On Feb 21, Cartier announced its selected 18 finalists from among 1,800 applications from over 130 countries, distinguished by the impact they are making in ensuring safe and dignified santitation; in improving healthcare and social ca
April 26, 2018

These two sectors helped bring 2017 customer satisfaction levels to a new high: Survey
SINGAPORE (Mar 28): Singapore’s national customer satisfaction hit a new high in 2017, according to the 2017 Customer Satisfaction Index of Singapore (CSISG) released by the Institute of Service Excellence (ISE) at the Singapore Management University (S
March 28, 2018









